19.12.2017Biopôle recrute un/e Responsable de LaboratoireYou are hereNewsBiopôle recrute un/e Responsable de Laboratoire
Toutes les informations concernant les postes sont disponibles suivant ce lien.
Find an actor
BioAlps World Visibitlity Package 201918.03.2019A yearly international programme for our affiliated companies to increase their visibility.
BioAlps World Visibitlity Package 2019A yearly international programme for our affiliated companies to increase their visibility.
iOnctura SATherapeutics & Diagnostics
iOnctura, headquartered in Geneva, Switzerland, was founded in June 2017 as a spin out from Merck KGaA, funded by Merck Ventures. It is a late stage preclinical biotechnology company developing a pipeline of next generation, best-in-class molecules for the treatment of cancer and fibrosis.
Therapeutics & Diagnostics, Antibodies / Anti-infectives
Therapeutics & Diagnostics, Chemical Drug, small Molecules
Programs in oncology aim to harness both immune-mediated and direct anti-tumour activity to deliver superior clinical efficacy in monotherapy or combinations. By building on complementary mechanisms between cancer and fibrosis iOnctura further aims to address high unmet need in fibrotic disease.